Parlux sales jump 83.1% to $25.5 mil. in FY 1997 second quarter.
This article was originally published in The Rose Sheet
Executive SummaryPARLUX SALES JUMP 83.1% TO $25.5 MIL. IN SECOND QUARTER OF FY 1997, up from $13.9 mil. during the prior-year period, the company reported Nov. 11. Net earnings during the quarter (ended Sept. 30), advanced 42.5% to $2.1 mil., versus $1.5 mil. in the comparable quarter of 1995. Operating income rose 32.5% to $4 mil. during the three-month period
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.